| Aristea Sideri Gugger, MD, PHD | |
|
11 Overlook Rd Bldg Suite195, Summit, NJ 07901-3577 | |
| (908) 522-6995 | |
| (908) 522-5535 |
| Full Name | Aristea Sideri Gugger |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 11 Overlook Rd Bldg Suite195, Summit, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235661299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 25MA11842200 (New Jersey) | Primary |
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Avid Bioservices, Inc. today presented data highlighting the comparability of production run performance between the company's single-use bioreactors (Thermo Scientific HyClone S.U.B.) and its traditional stainless steel bioreactors at the Thermo Scientific BioProduction Optimization Workshop in San Francisco, California.
Today's headlines mark the health law's official first birthday and examine where the related policies and politics now stand.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate/Benazepril 5/20mg, 10/20mg, 2.5/10mg, and 5/10mg capsules, the generic equivalent to Novartis' Lotrel capsules.
The ROMaN Project, Inc. announces its endorsement of the Food and Drug Administration's (FDA) guidance to utilize risk-based monitoring in clinical trials. Risk-based monitoring focuses attention to the most critical data elements in a study and allocates monitoring resources to the investigator sites with problematic or unproven protocol compliance and/or data integrity.
The landmark Patient Protection and Affordable Care Act (ACA) presents local governments with both challenges and opportunities. As the various provisions of the legislation go into effect, local government leaders are retooling their healthcare plans to improve health and reduce costs, while also playing an important role in the law's implementation at the local level.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aristea Sideri Gugger, MD, PHD Po Box 416457, Boston, MA 02241-6457 Ph: (844) 362-1735 | Aristea Sideri Gugger, MD, PHD 11 Overlook Rd Bldg Suite195, Summit, NJ 07901-3577 Ph: (908) 522-6995 |
News Archive
Avid Bioservices, Inc. today presented data highlighting the comparability of production run performance between the company's single-use bioreactors (Thermo Scientific HyClone S.U.B.) and its traditional stainless steel bioreactors at the Thermo Scientific BioProduction Optimization Workshop in San Francisco, California.
Today's headlines mark the health law's official first birthday and examine where the related policies and politics now stand.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate/Benazepril 5/20mg, 10/20mg, 2.5/10mg, and 5/10mg capsules, the generic equivalent to Novartis' Lotrel capsules.
The ROMaN Project, Inc. announces its endorsement of the Food and Drug Administration's (FDA) guidance to utilize risk-based monitoring in clinical trials. Risk-based monitoring focuses attention to the most critical data elements in a study and allocates monitoring resources to the investigator sites with problematic or unproven protocol compliance and/or data integrity.
The landmark Patient Protection and Affordable Care Act (ACA) presents local governments with both challenges and opportunities. As the various provisions of the legislation go into effect, local government leaders are retooling their healthcare plans to improve health and reduce costs, while also playing an important role in the law's implementation at the local level.
› Verified 5 days ago
Manoj M Trivedi, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 802 Old Springfield Ave, Summit, NJ 07901 Phone: 908-273-5644 Fax: 908-273-1435 | |
Dr. Olumuyiwa Adedotun Ibikunle, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
Sona Khurana, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-6414 | |
Asma Jafri, Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
David Jordanovski, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-2000 | |
Andrew Toscano, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Springfield Ave, Summit, NJ 07901 Phone: 973-656-6280 | |
Nisha Suresh Kotecha, M.B.B.S. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Springfield Ave, Summit, NJ 07901 Phone: 908-934-0555 |